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Osteoarthritis (OA) is the most common human joint disease, characterized by loss and/or remodeling of joint
synovium, cartilage, and bone. Here, we describe a genomewide linkage analysis of patients with idiopathic hand
OA who were carefully phenotyped for involvement of either or both the distal interphalangeal (DIP) joints and
the first carpometacarpal (CMC1) joints. The best linkage peaks were on chromosomes 4q and 3p and on the
short arm of chromosome 2. Genomewide significance was reached for a locus on chromosome 2 for patients with
affected CMC1 joints (LOD p 4.97); this locus was also significant for patients with OA in both CMC1 and DIP
joints (LODp 4.44). The peak LOD score at this locus coincides with a gene,MATN3, encoding the noncollagenous
cartilage extracellular matrix protein, matrilin-3. Subsequent screening of the genomic sequence revealed a missense
mutation, of a conserved amino acid codon, changing threonine to methionine in the epidermal growth factor–like
domain in matrilin-3. The missense mutation cosegregates with hand OA in several families. Themutation frequency
is slightly more than 2% in patients with hand OA in the Icelandic population and has a relative risk of 2.1.
Introduction
Osteoarthritis (OA [MIM 165720]) is the most common
form of musculoskeletal disability in the developed coun-
tries (Lawrence et al. 1998). Clinical problems include
pain and joint stiffness often leading to significant dis-
ability and joint replacement (Creamer and Hochberg
1997). OA exhibits a clear predilection for specific joints;
it appears most commonly in the hip and knee joints and
lumbar and cervical spine, as well as in the distal inter-
phalangeal (DIP) and the first carpometacarpal (CMC1)
(base of thumb) and proximal interphalangeal joints of
the hand; however, patients with OA may have one, a
few, or all of these sites affected. According to a conser-
vative estimate, 140 million people in the United States
alone are affected with OA, with 170% of the population
at age 65 years being affected by the disease, reflecting
its age dependence (Roberts and Burch 1966).
Pathologically, OA is characterized by a dynamic pro-
cess of destruction and repair of joint tissues. Its hall-
mark is decreased volume and disorganization of the
articular cartilage. Synovial-layer hyperplasia and cap-
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sular thickening also occur. Dramatic bone expansion,
especially near the edges of the joint (osteophyte forma-
tion), is also characteristic and may represent a reaction
to the loss of articular cartilage.
Articular cartilage is composed of chondrocytes and
the extracellular matrix (ECM). The chondrocytes syn-
thesize and maintain the ECM. The ECM is primarily
composed of collagen fibrils (mainly collagen II, with
less of types IX and XI) and proteoglycans (especially
aggrecan). The intersecting networks of collagens and
proteoglycans are linked together with a set of noncol-
lagenous matrix proteins. These networks are also tied
to the chondrocytes either directly or, more common-
ly, through hyaluronic acid and noncollagenous matrix-
linking proteins. The collagen network provides the ten-
sile and shear strength to the articular cartilage, whereas
the proteoglycan network, with itswater-absorbingprop-
erties, provides the compressile strength to absorb force
perpendicular to the joint surface. Normal articular car-
tilage may display balance, perhaps regulated by the non-
collagenous matrix proteins, between these two opposing
networks.
In OA, the earliest histological changes involve ede-
ma in the articular cartilage, suggesting an alteration in
the balance between the proteoglycan and collagen net-
works, tilted toward the water-absorbing properties of
the former. Indeed, in OA, there is gradual disorgani-
zation of the collagen fibril network, leading to loss of
integrity of the matrix networks, evident pathologically
in moderate and severe OA as cartilage delaminations
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Table 1
Primers Used for PCR Amplification of MATN3 Exons and Neighboring Regions for Detection
of Nucleotide Variation
Position
Forward Primer
(5′r 3′)
Reverse Primer
(5′r 3′)
Exon 1 AGTTTCCCCCACAGGATTCA CCCAGACATTCCGTTTCTGC
Exon 2 TGTTTAGGTTGGTCGCACACAC GTCGAATCACACCCTTGTCAAC
Exon 2 GTCGAATCACACCCTTGT GCCTCCCATCTGTAACAA
Exon 2 GCCTCCCATCTGTAACAATGAT ATGTTGGGGTCAGGAGATGC
Exon 3 TTCAGGGAAAACTGCTGA AGCATTGCTAATAAGCCAG
Exon 3 TTCAGGGAAAACTGCTGATGAA AGCATTGCTAATAAGCCAGAGG
Exon 4 TTTGGGCCGAGATACATACA GCCCCTCCCTTGTTTCATTAG
Exon 5 TGAGCAATGTGTGCCTTCATCT CAGTGCCAATGGCTTTGAATAG
Exon 6 TCTGACAGGGAGAAAGAATCACA GGCCTGTTGCTGACTACTGACT
Exon 7 TAGGGGACAAAATAGGCAGCTT CCTCTTGGAAAATGCACTTAGG
Exon 8 TTGAAGCCTTTCTTTTGAACCT TTTGCTTCAGGATCCAAGTGAC
Exon 8 AAAAAGTTAGACTTTCAAGCCTGT TGACTGTGAAATGATTGGTAGGAA
Exon 8 AGACCTAAAGTTTCCATTGTGAAT TGTGCTCTCTGAAGAACAGGATTT
Indel1 GTTTCTGCCGCTGGAATG CCAGAGCAGCAGGAGGAG
and clefts. This process advances to include the deep
layer of cartilage near the endochondral bone. The joint
appears to respond with reparative and compensatory
processes—such as chondrocyte proliferation and hy-
pertrophy, as well as fibrocartilage production at the
articular bone surface, sometimes leading to bony pro-
jections called “osteophytes.”
OA has been considered as a degenerative disease that
results from everyday wear and tear or trauma of the
joint. Indeed, damaged joint integrity owing to trauma
or inflammation will often lead to secondary OA. In
addition, large body weight increases the risk of knee
OA (Cicuttini et al. 1997). However, numerous epide-
miological studies have showed increased risk to rela-
tives of patients with idiopathic OA. These studies in-
clude hip OA (Ingvarsson et al. 2000) and hand OA
(Stecher 1941). Although there are rare families of pa-
tients with OA that have a Mendelian inheritance pat-
tern, these patients have an unusual form of OA usually
associated with dwarfism, congenital or early-onset ana-
tomic abnormalities of joint, and osteochondrodyspla-
sia. In general, the common forms of OA appear to skip
generations, with unclear patterns of inheritance. Thus,
OA most likely represents the confluence of environ-
mental factors and multiple disease genes.
Several studies have suggested that OA of the hand
has a significant genetic component. Previous studies
found Heberden nodes (osteophytes of the DIP joint) to
be three times more common in sisters of affected indi-
viduals than in the general population (Stecher 1941),
and a genetic contribution has been estimated to be as
much as 65% in patients with OA of the hand or knee
(Spector et al. 1996; Bijkerk et al. 1999). Furthermore,
sisters of patients with OA in the CMC1 joint have an
almost sevenfold risk of the development of OA in the
same joint (Jonsson et al. 2003).
Several genomewide linkage scans attempting to
map genes that contribute to the common forms of
OA have been reported. These have focused on either
OA of the hand or OA of the large joints. None of
the reported scans meet the criteria for genomewide
significance. However, these studies reveal several sug-
gestive loci for OA. Hip OA shows suggestive linkage
to 2q, 4q (female hip OA), 4q35 (early-onset OA), 6p,
6q, 11q (female OA), 16p, and 16q (both the common
form and a familial early-onset form) (Chapman et al.
1999; Leppa¨vuori et al. 1999; Loughlin et al. 1999,
2002; Roby et al. 1999; Ingvarsson et al. 2001). Hand
OA shows suggestive linkage to 1p, 2p, 2q12-13,
2q23-35, 4q26-27, 7p15-21, 9q, 11q, 12q, 13q, and
X-cen (Wright et al. 1996; Leppa¨vuori et al. 1999;
Demissie et al. 2002). Of interest, 2q and 16p have
appeared in more than one population. Together, these
studies demonstrate that stratification of OA by phe-
notype appears to bring out loci that may have cor-
relation to particular joints. However, there are prob-
ably also genes that contribute to OA in general.
For the present study, we chose to focus on a subtype
of OA, namely hand OA, that fulfills rigorous inclusion
criteria. We used the genealogical approach to cluster
large numbers of patients with well-defined hand OA,
and we mapped hand OA to three prominent locations
on chromosomes 2, 3, and 4. The present article also
describes a mutation in MATN3, the gene that encodes
matrilin-3 (MIM 602109), with an association in a mi-
nority of patients with hand OA.
Patients and Methods
Patients
A list of patients with OA of the hand was obtained
on the basis of patients’ records at hospitals and health
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Table 2
Sequence Polymorphisms in MATN3, along with Estimated Relative Risks and Patient and Control Frequencies—in an Initial Screening Set
of 78 Patients and 18 Control Individuals and in a Follow-Up Cohort of 745 Patients and 368 Control Individuals
MARKER
(POSITION IN
AC079145a) POLYMORPHISM
PREDICTED
AMINO ACID
CHANGE ALLELE
INITIAL SCREENING SET FOLLOW-UP COHORT
Relative
Risk
Frequency among
Relative
Risk
Frequency among
Affected
Individuals
( )Np 78
Control
Individuals
( )Np 18
Affected
Individuals
( )Np 745
Control
Individuals
( )Np 368
Indel1 (38383) gcgggg(cggggcgggg)cccgag Insertion 1.15 .535 .500 1.16 .697 .665
SNP1 (38496) gcctcYcggga Ser/Pro T  .007 .000
SNP2 (45010) caggcYgtggg T 1.10 .412 .389 1.17 .424 .387
SNP3 (45178) gaatgaRgtggc A 1.10 .412 .389 1.16 .425 .390
SNP4 (45317) gtcattRagaaa Glu/Lys A 2.11 .987 .972 1.24 .977 .980
SNP5 (47928) agaaaaYgtgtt Met/Thr T  .067 .000 4.34 .017 .004
SNP6b (47929) gaaaacRtgttc G 1.62 .787 .694
SNP6b (47929) gaaaacRtgttc A 1.32 .279 .226
NOTE.—For details on the sequence polymorphisms shown here, see the IUPAC Ambiguity Codes Web site.
a For details, see GenBank (sequences AC079145, 7844257, 7844258, 7844259, 7844260, 7844261, 7844262, and 7844263).
b For SNP6, the at-risk allele differed in the screening set and in the follow-up cohort.
care centers in Iceland. The encrypted patient list was
cross-referenced with our comprehensive Icelandic gene-
alogy database (Gulcher and Stefansson 1998; Gulcher et
al. 2000), and pedigrees with two or more affected in-
dividuals related at or within five meioses were identified.
Patients within these families and as many as three first-
degree relatives were recruited and examined by a rheu-
matologist (H.J.) or an orthopedic surgeon (T.I.). Ad-
ditionally, a group of patients and their relatives from
another ongoing study of hip OA and knee OA also had
their hands examined for the present study. Individuals
were classified as having idiopathic hand OA if they met
either or both of the following two criteria: (1) OA with
a minimum of two nodes at the DIP joints on each hand
(hereafter, “DIP phenotype”), or (2) OA of the thumb
with squaring or dislocation of a CMC1 joint (hereafter,
“CMC1 phenotype”). Only individuals with idiopathic
OA were included in the patient cohorts. Included in the
linkage analysis were 1,143 affected individuals, along
with 939 of their relatives. For the mutational analysis,
1,077 of the affected individuals from the linkage group,
along with an additional 1,085 affected individuals and
a group of 873 unrelated Icelandic control individuals,
participated. The present study was approved by the Data
Protection Commission of Iceland and the National Bio-
ethics Committee of Iceland. Informed consent was ob-
tained from all participants.
Microsatellite Markers and Maps
Our framework genomewide scan uses a 1,000-mi-
crosatellite-marker set that contains markers from the
ABI Linkage Marker (version 2) screening and inter-
calating sets, in combination with 500 custom-made
markers. All markers were extensively tested for ro-
bustness, ease of scoring, and efficiency in multiplex
PCR. Marker positions were obtained from our genetic
map (Kong et al. 2002). All reported marker positions
are in Kosambi centimorgans. In our framework set,
the average spacing between markers is ∼4 cM. PCR
amplifications were set up, run, and pooled on Gilson
Cyberlab robots. The reaction volume was 5 ml, and,
for each PCR, 20 ng genomic DNA was amplified in
the presence of 2 pmol each primer, 0.25 U AmpliTaq
Gold, 0.2 mM dNTPs, and 2.5 mM MgCl2 (buffer was
supplied by the manufacturer [Applera]). Cycling con-
ditions were as follows: 95C for 10 min, followed by
37 cycles of 94C for 15 s, annealing at 55C for 30
s, and extension at 72C for 1 min. The PCR products
were supplemented with the internal size standard, and
the pools were separated and detected on ABI Prism
3700 sequencers by use of Genescan (version 3.0) peak-
calling software (Applera). Alleles were automatically
called using DAC, an allele-calling program developed
at deCode Genetics (Fjalldal et al. 2001), and the pro-
gram DecodeGT was used to fractionate the called ge-
notypes according to quality and to edit when necessary
(Pa´lsson et al. 1999).
Statistical Methods for Linkage Analysis
We used multipoint, affected-only allele-sharing
methods to assess the evidence for linkage. All results,
including LOD and nonparametric linkage scores, were
obtained using the program Allegro (Gudbjartsson et
al. 2000). We used the Spairs scoring function (Whitte-
more and Halpern 1994; Kruglyak et al. 1996) and an
exponential allele-sharing model (Kong and Cox 1997)
to generate the relevant 1-df statistics. When combining
the family scores to obtain an overall score, instead of
weighting the families equally (the default of Gene-
hunter [Kruglyak et al. 1996]) or weighting the af-
fected pairs equally, we used a weighting scheme that
is halfway between the two in the log scale; our family
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Table 3
Summary of LOD Scores 11 for the Framework
Genomewide Scans of Four Hand-OA Cohorts
Cohort and LOD
Score
Chromosome
(Marker)
Location
(cM)
Hand OA:
1.48 2 (D2S146) 51.5
1.14 2 (D2S2277) 160.4
1.79 3 (D3S3551) 96.8
1.00 3 (D3S1279) 160.2
2.61 4 (D4S3046) 155.9
1.05 6 (D6S270) 134.9
1.08 7 (D7S664) 26.0
1.14 7 (D7S559) 183.0
DIP:
1.13 2 (D2S2324) 160.8
2.20 3 (D3S1566) 94.8
2.58 4 (D4S2980) 153.9
1.33 6 (D6S460) 90.6
1.20 6 (D6S270) 134.9
1.02 7 (D7S798) 169.9
1.18 11 (D11S987) 72.2
CMC1:
2.23 2 (D2S2168) 48.0
1.15 3 (D3S3614) 99.1
1.70 4 (D4S3046) 155.9
DIP/CMC1:
1.17 3 (D3S3614) 99.1
1.09 3 (D3S1565) 177.9
1.24 4 (D4S3046) 155.9
weights are the geometric means of the weights of the
two schemes. Although not identical, this weighting
scheme tends to give similar results to that proposed
by Weeks and Lange (1988) as an extension of a
weighting scheme of Hodge (1984) designed for sib-
ships. We computed the P value in two different ways
and report the less significant one. The first P value
was computed on the basis of large sample theory;
is distributed approximately asZ p 2 log (10)LODlr e
a standard normal random variable under the null hy-
pothesis of no linkage (Kong and Cox 1997). Further-
more, because of the concern with small-sample be-
havior, we computed a second P value by comparing
the observed LOD score to its complete data sampling
distribution under the null hypothesis (Gudbjartsson et
al. 2000). When a data set consists of more than a
handful of families, which is the case here, these two
P values tend to be very similar. To ensure that the
results were a true reflection of the information con-
tained in the material (i.e., for us to consider a linkage
result significant), we required not only that the P value
be ! (Lander and Kruglyak 1995) but also that52# 10
the information content in the region be 85%. For
the families in the present study, an information content
of 85% corresponded to a marker density of approx-
imately one marker every centimorgan. The informa-
tion measure that we used has been defined elsewhere
(Nicolae 1999) and is implemented in Allegro. This
measure is closely related to a classical measure of in-
formation (Dempster et al. 1977), having the property
that it is between 0, if the marker genotypes are com-
pletely uninformative, and 1, if the genotypes deter-
mine the exact amount of allele sharing by descent
among the affected relatives.
Mutational and Association Analyses
To identify polymorphisms within the MATN3 gene,
primers were designed for PCR amplification of all known
exons and the promoter sequence of the MATN3 gene
(table 1). DNA from 76 patients from families that scored
positive in a nonparametric linkage analysis for the mark-
ers under the peak of the LOD score and DNA from 18
control individuals were initially sequenced for polymor-
phism within the gene. Both the forward and reverse
strands were sequenced on an ABI Prism 3700 DNA an-
alyzer. Some of the variants identified were further ex-
amined for association with hand OA, usually by using
a SNP assay applied to a follow-up cohort of 745 patients
and 368 control individuals and applying the fluorescent
polarization (FP) method (Chen et al. 1999). For the ge-
notyping of SNPs, markers were designed adjacent to
each polymorphic site (table 2) and were genotyped us-
ing the FP method. One variant was further assessed by
FP in all patients with hand OA and in a total of 873
control individuals. A microsatellite marker, Indel1, was
designed around a polymorphic repeat in the purported
Sp1 promoter element (Wagener et al. 2000), resulting
in one or two putative Sp1 elements.
Haplotype Analysis
To handle missing genotypes and uncertainty as to
phase, we applied our own implementation of the like-
lihood approach (Stefansson et al. 2002), using the ex-
pectation-maximization algorithm as a computational
tool, to estimate the haplotype frequencies (Dempster
et al. 1977). Under the null hypothesis, the affected in-
dividuals and control individuals are assumed to have
identical frequencies of all haplotypes. Under the alter-
native hypothesis, the candidate at-risk haplotype is al-
lowed to have a higher frequency in affected individuals
than in control individuals, whereas the ratios of the
frequencies of all other haplotypes are assumed to be
the same in both groups. Likelihoods are maximized
under both hypotheses, and a corresponding 1-df like-
lihood-ratio statistic is used to evaluate statistical sig-
nificance.
Results
Genome Scan
A genomewide linkage scan was performed for 329
families—altogether containing 1,143 individuals with
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Table 4
Summary of Three Genomewide Linkage Scans for Various OA Phenotypes
Chromosome
(Marker[s]a)
Locationb
(cM) Evidencec Referenced
1 (D1S1665) 99.6 LOD p 2.96 Demissie et al. 2002
2 (D2S405) 51.5 LOD p 2.23 Demissie et al. 2002
2 (D2S1399) 155 P p .007 Leppa¨vuori et al. 1999
2 (IL1R1) 116.1 P p .0001 Leppa¨vuori et al. 1999
4 (D4S2394) 128.1 P p .0001 Leppa¨vuori et al. 1999
7 (D7S664–D7S673) 13–39.5 P p .001 Leppa¨vuori et al. 1999
7 (D7S817) 52.2 LOD p 2.32 Demissie et al. 2002
9 (D9S1122) 74.3 LOD p 2.29 Demissie et al. 2002
11 (D11S901) 88.5 MLS p 3.51 Chapman et al. 1999
a Marker names as reported in the respective studies.
b Our estimates (in Kosambi cM).
c All linkage peaks with multipoint LOD score (MLS) 12 or P value !.01, as reported
in the three genomewide linkage scans.
d Chapman et al. studied families with at least two siblings with total knee or total
hip replacement, Leppa¨vuori et al. studied families with members affected with radio-
graphic OA in DIP joints, and Demissie et al. used Kellgren/Lawrence grading, os-
teophytes, and/or joint-space narrowing in hand joints.
idiopathic hand OA, along with 939 genotyped rela-
tives. Each family contained at least two affected in-
dividuals related to each other at or within five meioses.
The results of the linkage scan are displayed in figure
1. The highest LOD score was observed on chromo-
some 4 (LOD p 2.61 [D4S3046, at 155.9 cM]). The
next highest LOD scores were obtained on chromo-
somes 3 (LOD p 1.79 [D3S3551, at 96.8 cM]) and 2
(LODp 1.48 [D2S146, at 51.5 cM]). Other peaks with
LOD scores 11 were obtained on chromosomes 6 and 7.
To study the effects that the subphenotypes had on
the linkage results, we performed three additional ge-
nomewide scans, in which individuals were considered
affected if they had the DIP phenotype (hereafter, “DIP
cohort”), the CMC1 phenotype (hereafter, “CMC1 co-
hort”), or both the DIP and CMC1 phenotypes (here-
after, “DIP/CMC1 cohort”). The DIP cohort scan in-
cluded 944 affected individuals in 274 families, the
CMC1 cohort scan included 558 affected individuals
in 204 families, and the DIP/CMC1 cohort scan in-
cluded 382 affected individuals in 142 families.Table
3 indicates the location and size of all peaks with a
LOD score 11 for these four genomewide scans. Only
three locations—one on each of chromosomes 2, 3, and
4—achieved a LOD score 2 in at least one of the four
scans. The LOD scores in these locations are 2.23 at
D2S2168, on chromosome 2, for the CMC1 cohort;
2.20 at D3S1566, on chromosome 3, for the DIP co-
hort; and 2.61 at D4S3046 and 2.58 at D4S2980, on
chromosome 4, for the hand-OA and DIP cohorts, re-
spectively. Some of our peaks may overlap with the
previously reported location for linkage (see table 4).
In particular, our linkage to the p arm of chromosome
2 is close to a peak that has recently been reported by
Demissie et al. (2002). We added markers in these three
regions to increase the information content on allele-
sharing among affected relatives. The results of the
linkage scans with the additional markers on chromo-
somes 2, 3, and 4 are displayed in figure 2. These fine-
mapping results show that the evidence for linkage on
chromosome 3 changed very little—decreasing slight-
ly for the hand-OA and DIP cohorts and increasing
slightly for the other two cohorts. Chromosome 4 exhib-
ited slightly decreased evidence for linkage in the CMC1
cohort but increasing evidence in the other cohorts,
with a LOD score 13 in the DIP cohort (LOD p 3.29
[D4S2982]). The most striking result, however, was the
increased evidence for linkage on chromosome 2 for all
cohorts, with a LOD score of 4.97 between D2S175 and
D2S2201 for the CMC1 cohort ( ). This7Pp 8.5# 10
latter LOD score remains significant even after correc-
tion for the four genomewide scans. For the CMC1 co-
hort, the size of the region, on chromosome 2, that has
a LOD score within one of the peak LOD scores is a
little more than 5 cM, from D2S175 (at 41.9 cM) to
D2S1324 (at 47.1 cM). Table 5 summarizes the fine-
mapping linkage results for these three loci, indicating
the peak marker(s) and its genetic locations.
Mutational Analysis
On the basis of these results—and, primarily, the result
in the CMC1 cohort—we have an ongoing association
analysis at the chromosome 2 locus. In addition, we have
also searched for possible nearby candidate genes. Six
publicized genes were found to be within a 4-Mb region
centered on the chromosome 2 peak (see the Human
Genome Browser Gateway Web site). One of the genes,
MATN3, is located within 100 kb of the LOD-score
peak, and a recent publication implicated mutations in
Fi
gu
re
2
Fi
ne
-m
ap
pi
ng
re
su
lt
s
fo
r
ch
ro
m
os
om
es
2,
3,
an
d
4
fo
r
th
e
co
ho
rt
s
w
it
h
id
io
pa
th
ic
ha
nd
O
A
an
d
th
e
D
IP
,
C
M
C
1,
an
d
D
IP
/C
M
C
1
ph
en
ot
yp
es
.
T
he
al
le
le
-s
ha
ri
ng
L
O
D
sc
or
e
is
gi
ve
n
on
th
e
Y
-a
xi
s,
an
d
th
e
ge
ne
ti
c
lo
ca
ti
on
(i
n
K
os
am
bi
cM
)
is
gi
ve
n
on
th
e
X
-a
xi
s.
Stefa´nsson et al.: Hand OA and Matrilin-3 1455
Table 5
Summary of Peak LOD Scores after Fine Mapping in Four Hand-OA
Cohorts
Locus and Cohort LOD Score Peak Location (Marker[s])
Chromosome 2:
Hand OA 2.42 44.0 (D2S175, D2S2201)
DIP 2.44 44.0 (D2S175, D2S2201)
CMC1 4.97 44.0 (D2S175, D2S2201)
DIP/CMC1 4.44 44.0 (D2S175, D2S2201)
Chromosome 3:
Hand OA 1.62 96.1 (D3S1562)
DIP 1.84 96.1 (D3S1562)
CMC1 1.42 107.2 (D3S1274)
DIP/CMC1 1.27 107.2 (D3S3049)
Chromosome 4:
Hand OA 2.91 154.1 (D4S2982)
DIP 3.29 154.1 (D4S2982)
CMC1 1.60 155.9 (D4S3046)
DIP/CMC1 1.42 155.5 (D4S2993)
Figure 3 Allelic variation in MATN3. The top chromatogram
shows the nucleotide sequence for an individual homozygous for the
allele for the predicted missense mutation resulting in methionine res-
idue (ATG codon). The center chromatograph depicts the sequence
for an individual heterozygous for the allele, and the bottom chro-
matograph shows the sequence for an individual homozygous for the
threonine residue (ACG codon). The nucleotide highlighted in red de-
picts the polymorphic allele.
this gene in a class of dysplasias of large joints with as-
sociated early-onset OA (Chapman et al. 2001).MATN3
encodes matrilin-3, a noncollagenous ECM protein with
restricted expression in articular cartilage and bone tis-
sues (Klatt et al. 2000). We screened 76 patients and 18
control individuals for mutations in the exons ofMATN3
and identified six exonic SNPs and a putative promoter
polymorphism that is biallelic—consisting of an inser-
tion or deletion of two pentanucleotide repeats (table 2,
“Initial Screening Set”). The initial screening indicated
one very rare SNP (namely SNP1, with allele frequency
!1% in patients) and one promising SNP (namely SNP5,
with allele frequency 16% in patients and nearly nonexis-
tent in control individuals). We decided to test five of the
SNPs and the promoter in a larger cohort, of 745 patients
and 368 control individuals. Only one of the variants,
SNP5, showed more than marginal excess in patients (ta-
ble 2, “Follow-Up Cohort”) and involves a nucleotide
change from cytidine to thymidine in the third exon of
the gene, predicting a substitution of a threonine by a
methionine residue at position 303 (hereafter, “T303M”)
in the first epidermal growth factor (EGF) domain of the
protein (fig. 3). This threonine residue is conserved in all
four of the EGF domains in the coding sequences for
MATN3 in human, chicken, and mouse (fig. 4). The ob-
served frequency of just under 2% for this SNP seemed
more likely than the previously observed frequency for
the screening set, since the screening set was weighted
toward the patients in families with linkage. Tomore fully
investigate the contribution that this mutation makes to
hand-OA risk in Iceland, we decided to type the entire
patient set. A total of 2,162 patients and 873 control
individuals were typed for this coding SNP. Among the
patients, 1,312 had the CMC1 phenotype. The results
of the mutation screening are displayed in table 6. Of
the 873 control individuals, 9 were heterozygous and
0 were homozygous for the mutation, whereas, of the
2,162 patients, 43 were heterozygous and 2 were ho-
mozygous for the mutation. The estimated relative risk
of hand OA for carriers of a single copy of the mutation
as compared to the noncarrier under the multiplicative
model is 2.12. Both of the homozygous carriers and 31
of the 43 patients heterozygous for the mutation had
the CMC1 phenotype. This led to an estimated relative
risk for the CMC1 phenotype of 2.61, which is slightly
higher than that for idiopathic hand OA.
We observed that 30 of the 45 carriers of this mutation
were in the families with linkage, including both homo-
zygous carriers. We then performed a linkage analysis
for the CMC1 cohort less the mutation carriers, to assess
the effect that these carriers had on the locus. The LOD
score at the chromosome 2 peak dropped to 3.80, which
demonstrates that, although these carriers have a signifi-
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Figure 4 Alignment of amino acid residues for all four EGF domains of matrilin-3 from human (HuEGF1–4), mouse (MouEGF1–4),
and chicken (ChEGF1–4). Residues conserved in all EGF domains are highlighted in green. The predicted missense mutation at position 303
in MATN3 from human protein sequence changes the threonine residue (boldface) to methionine.
Table 6
Association Analysis of a MATN3 Mutation, SNP5, in Four Hand-OA Cohorts
Cohort Relative Risk (95% CI)a
No. of Affected
Individuals
No. of Mutations
among Affected
Individuals
No. of Control
Individuals
No. of Mutations
among Control
Individuals
Hand OA 2.12 (.92–4.86) 2,162 47 873 9
DIP 2.06 (.85–4.97) 1,801 38 873 9
CMC1 2.61 (1.05–6.48) 1,312 35 873 9
DIP/CMC1 2.67 (1.07–6.68) 951 26 873 9
a Adjusted for family relationships.
cant impact on the linkage, there are likely to be as-yet-
undetected associations between hand OA and either
MATN3 or other genes in the region.
We also assessed the common haplotype background
of the gene for association to idiopathic hand OA. Using
the three exonic SNPs with minor-allele frequency 15%
and the promoter polymorphism, five haplotypes with
estimated allelic frequency of 11% in the population
were identified, accounting for 199% of all haplotypes
in the region. The haplotypes and their estimated risks
are displayed in table 7. Only one of these haplotypes
shows a slight and insignificant excess risk. Interestingly,
it is the second least frequent haplotype that is the back-
ground for the mutation that we report. Considering
only the subset of patients with the CMC1 phenotype
has no appreciable effect on these results. We continue
to investigate this region for other at-risk variants.
Discussion
MATN3 is an interesting candidate gene for OA. It is
a noncollagenous ECM protein that is one of a class
of four related proteins, termed “matrilin-1” through
“matrilin-4.” All four matrilins are expressed in the de-
veloping skeletal system, but matrilin-3 exhibits the ex-
pression pattern most restricted to developing cartilage,
especially the epiphyseal cartilage. The matrilins are com-
posed of vonWillebrand factor A (vWFA) domains, EGF-
like repeats, and a C-terminal a-helical coiled-coil domain.
Matrilin-3 is composed of a single N-terminal vWFA do-
main followed by four EGF repeats and the coiled-coil
domains, whereas the other matrilins are each composed
of two vWFA domains, separated by 1–10 EGF repeats,
followed by the C-terminal coiled-coil domain. The
coiled-coil domains mediate covalent multimer formation
among the matrilins, through their heptad repeats and
two cysteines. The matrilins form homomultimers and
heteromultimers in almost every combination with each
other in proportion to the concentration of each subunit.
Matrilin-3 forms heteromultimers only with matrilin-1,
and these are heterotetramerswith two subunits each.The
vWFA domain is a collagen binding domain in other pro-
teins, and matrilin-1 has been shown to bind to type II
collagen fibrils in cartilage in a periodic pattern.Matrilin-
1 also interacts with aggrecan and may also bind to in-
tegrin a1b1 (Makihira et al. 1999). Therefore, matrilin-1
may represent the link between the collagen fibril network
and the proteoglycan network, as well as a connection to
the chondrocytes. Indeed, mice without matrilin-1 de-
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Table 7
Association Study of MATN3 Haplotypes Common to Idiopathic Hand OA in a Follow-Up Cohort of
745 Patients and 368 Control Individuals
LABEL
RELATIVE
RISK
FREQUENCY AMONG ALLELE AT
Affected
Individuals
( )Np 745
Control
Individuals
( )Np 368 Indel1 SNP1 SNP2 SNP6
Hap1 .92 .288 .306 Insertion C G G
Hap2 .88 .284 .310 Deletion C G G
Hap3 1.31 .273 .223 Insertion T A A
Hap4a .93 .132 .140 Insertion T A G
Hap5 .49 .012 .016 Deletion T A G
a Haplotype background of reported mutation.
velop normally but show ultrastructural changes in fibril
networks in cartilage (Huang et al. 1999). The gene that
encodes matrilin-1 would be an excellent candidate gene
for OA on the basis of its interaction with the collagen
and proteoglycan networks. Several groups have analyzed
the association between hip OA and a microsatellite poly-
morphism in the 3′ UTR of the gene that encodesmatrilin-
1. A Dutch cohort, stratified on males, found a significant
association between an allelic polymorphism and hipOA.
In contrast, British and Argentinean cohort studies failed
to replicate these results in their population (Meulenbelt
et al. 1997; Loughlin et al. 2000; Strusberg et al. 2002).
Matrilin-3 forms heterotetramers withmatrilin-1,with
higher affinity than either of the respective homomulti-
mers, and therefore may play a modulating role in the
cross-linking function of matrilin-1. Whereas matrilin-1
and matrilin-3 expression patterns overlap in cartilage,
matrilin-3 expression is higher thanmatrilin-1 expression
in the proliferation zone, where there are mainly noncol-
lagenous filaments, whereas matrilin-1 has the higher ex-
pression in the mature zone, where the collagen-proteo-
glycan network is more extensive. If matrilin-1 facilitates
collagen fibril formation and binding to proteoglycan,
then matrilin-3 may play an inhibitory role in normal
development and maintenance of cartilage and bone. If
there is too much matrilin-3 because of increased syn-
thesis or decreased breakdown, then these matrilin-1
roles may be impaired. It has recently been shown that
there is increased expression of matrilin-3 in joint car-
tilage of patients with OA, both at the RNA level and
at the protein level (Pullig et al. 2002). This could cer-
tainly be a reaction of the chondrocytes to an underlying
process in OA. However, our data suggest that matrilin-
3 may be primarily involved in OA, at least in some
patients with OA. Although we have found the T303M
mutation in only a small percentage of patients, there
may be other mutations affecting regulatory sequences
of matrilin-3. Other genes controlling expression, pro-
cessing, and turnover of matrilin-3 may lead to the in-
creased matrilin-3 observed in OA joints. The T303M
mutation in the first EGF repeat may favor heterotetra-
mer formation of both matrilin-1 and matrilin-3 over
homomultimer formation of each. Recent work has
showed that the number of EGF repeats in matrilin-3
does not affect the formation of homotrimers; however,
that study did not address a possible regulatory role for
EGF repeats on heterotetramer formation (Zhang and
Chen 2000). Previously characterized mutations in the
coding region for the vWFA domain of matrilin-3 cause
a rare autosomal dominant form of multiple epiphyseal
dysplasia and short stature with early onset of OA in
adulthood (Chapman et al. 2001). These mutations
have a high penetrance and mainly affect the hips and
knees (Mortier et al. 2001), suggesting that a mutation
in the presumed collagen II binding domain of matrilin-
3 causes developmental abnormalities in the skeletal sys-
tem. In contrast, the T303M mutation reported here may
represent a more subtle variant of matrilin-3, since it
does not appear to cause skeletal deformities, epiphyseal
dysplasia, or short stature; instead, it appears to con-
tribute to an adult-onset OA that affects the hand joints
preferentially, and it is not associatedwith an early onset
or unusual form of OA. The full population-attributable
risk of matrilin-3 mutations will require more-extensive
screening of the gene in the Icelandic population and
in other populations, but, if confirmed, this mutation
would represent the first mutation that contributes to
a common form of OA.
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